Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each ...

For the quarter ended March 2024, Abbott (ABT) reported revenue of $9.96 billion, up 2.2% over the same period last year. EPS came in at $0.98, compared to $1.03 in the year-ago quarter. The reported ...

Abbott Laboratories (ABT) is set to release its Q1 earnings results, with analysts expecting a decline in profit but a rise ...

Healthcare-products firm Abbott Laboratories’ first-quarter earnings beat expectations, but second-quarter guidance was light ...

Abbott (ABT) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.96 per share. This compares to earnings of $1.03 per share a year ago. These figures are ...

Abbott Laboratories beat Wall Street estimates for quarterly profit on Wednesday on robust sales of its medical devices, but ...

Today, Benzinga's options scanner identified 9 options transactions for Abbott Laboratories. This is an unusual occurrence.

Mastercard has achieved impressive revenue and earnings growth rates, surpassing its closest rivals. Find out why I rate MA ...